How Biosimilars Differ from Biologics in Cost and Benefits

Increased affordability of biosimilars may have an impact on healthcare systems.

By: McKesson Medical Surgical Editorial Team

Read time: 1 minute

An overview of biosimilars and how they compare to biologics

Health systems and clinics considering the adoption of biosimilars for treatment should understand and consider how they compare to biologics. Biosimilar products are therapies that have the same therapeutic value and potency as their biologic counterparts, the use of biosimilar drugs may save money for both patients and providers. Increased affordability of the biosimilars may also have a meaningful impact on the healthcare system.

To learn more, read What are biosimilars? How biosimilars differ from biologics in cost & benefits.

Subscribe to our monthly Prescribed Perspectives newsletter to have our exclusive content delivered directly to your inbox!